A quinazoline and butenamide derivative that acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER.

Synonyms: BIBW 2992, Afatinib Maleate, BIBW2992, (2E)-N-(4-(3-Chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide, BIBW 2992MA2, Afatinib Dimaleate, BIBW-2992, 41UD74L59M, BIBW-2992MA2, 0, Afatinib, 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2E)-, V1T5K7RZ0B, BIBW 2992 MA2, BIBW-2992-MA2, BIBW2992 MA2, Gilotrif

Instance information

comment

2019; AFATINIB was indexed under QUINAZOLINES 2007-2018 ,2019 (2007)

identifier

D000077716

Instance relations